DOSSIER · 13F Holders · Q2 2026

DRUGS MADE IN AMER ACQ II CO

14 institutions still hold DRUGS MADE IN AMER ACQ II CO as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP G2851K120·14 13F holders·last filed Jun 30, 2026
Market cap
13F value held
$43M
visible holders
Holders
14
filers reporting
Concentration
46.76%
LMR Partners LLP #1
top holder share
AI Holders Summary · Q2 2026

14 institutions reported DRUGS MADE IN AMER ACQ II CO in Q2 2026. LMR Partners LLP leads at 46.8% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
LMR Partners LLP
CIK 0001578621
$20M2.0M0.08%Q2 2026
02
Westchester Capital Management, LLC
CIK 0001512805
$5M503K0.25%Q2 2026
03
TIG Advisors, LLC
CIK 0001358253
$5M500K0.23%Q1 2026
04
Verition Fund Management LLC
CIK 0001454027
$3M250K0.01%Q2 2026
05
BlueCrest Capital Management Ltd
CIK 0001610880
$3M250K0.08%Q2 2026
06
Kepos Capital LP
CIK 0001512020
$2M210K3.44%Q1 2026
07
HRT FINANCIAL LP
CIK 0001475597
$1M137K0.00%Q4 2025
08
L1 Global Manager Pty Ltd
CIK 0001878742
$1M100K0.72%Q2 2026
09
Walleye Capital LLC
CIK 0001758720
$1M100K0.00%Q2 2026
10
READYSTATE ASSET MANAGEMENT LP
CIK 0001900923
$1M100K0.04%Q4 2025
11
MASO CAPITAL PARTNERS Ltd
CIK 0001698093
$995K100K1.63%Q3 2025
12
Rangeley Capital, LLC
CIK 0001517796
$327K56K0.32%Q1 2026
13
Clear Street Group Inc.
CIK 0001881567
$82K8K0.00%Q2 2026
14
UBS Group AG
CIK 0001610520
$18K2K0.00%Q2 2026